Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 2 recruiting now early-phase tilt small index

Embryonal Carcinoma: early-phase trial registry

2 of 2 indexed Embryonal Carcinoma trials are currently recruiting, with more weight in Phase 1-2.

Corpus placement: #7,188 of 28,707 conditions by registered trial count.

2 US clinical trials · 2 currently recruiting · #7,188 of 28,707 conditions by registered trial count

Embryonal Carcinoma: 2 US clinical trials tracked, 2 recruiting.

Embryonal Carcinoma is the subject of 2 registered US clinical trials on ClinicalTrials.gov, 2 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is Children's Oncology Group, running 2 of these trials.

Enrollment posture brief

Registry condition embryonal-carcinoma

OPEN 2 | RECR 100% | LATE 0 | EARLY 1 | RANK #7188 | SPON 2

Nearest open-share peer: Aortic Arch Aneurysm (100% recruiting · 5 trials)

Embryonal Carcinoma (this)100%Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%
Open-enrollment share among volume-matched conditions near Embryonal Carcinoma

Embryonal Carcinoma lists 2 open slots (100% of 2 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Embryonal Carcinoma on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Embryonal Carcinoma is recruiting above its size-band peers.

    2 of 2 indexed trials (100%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Phase 21

Phase Distribution

PhaseTrial count
Phase 2 1

Top Sponsors

Named interventions

Most-linked intervention names on Embryonal Carcinoma records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Germline DNA Samples Other
1 trials
Tumor Specimen Collection Other
1 trials
Blood Sample Collection Procedure
1 trials
Ifosfamide Drug
1 trials
Filgrastim Biological
1 trials
Etoposide Drug
1 trials
Questionnaire Administration Other
1 trials
Biospecimen Collection Procedure
1 trials

US sites by state

Facility locations filed on Embryonal Carcinoma trials. A trial with sites in several states counts in each.

Minnesota 1 trials
Colorado 1 trials
California 1 trials
Arizona 1 trials
Arkansas 1 trials
Alabama 1 trials
Alaska 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Embryonal Carcinoma page

2 registered trials, 2 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Embryonal Carcinoma condition card totals 2 registered trials; most-linked intervention Germline DNA Samples; top US site state Minnesota. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.